Naito R, Kasai T. Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives. World J Cardiol 2015; 7(3): 119-124 [PMID: 25810811 DOI: 10.4330/wjc.v7.i3.119]
Corresponding Author of This Article
Takatoshi Kasai, MD, Cardio-Respiratory Sleep Medicine, Department of Cardiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo 113-8421, Japan. kasai-t@mx6.nisiq.net
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Mar 26, 2015; 7(3): 119-124 Published online Mar 26, 2015. doi: 10.4330/wjc.v7.i3.119
Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives
Ryo Naito, Takatoshi Kasai
Ryo Naito, Department of Cardiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
Takatoshi Kasai, Cardio-Respiratory Sleep Medicine, Department of Cardiology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan
Author contributions: All authors contributed equally to this editorial.
Conflict-of-interest: All of the authors declare no conflicts of interest related to this work.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Takatoshi Kasai, MD, Cardio-Respiratory Sleep Medicine, Department of Cardiology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo 113-8421, Japan. kasai-t@mx6.nisiq.net
Telephone: +81-3-38133111 Fax: +81-3-56890627
Received: December 3, 2014 Peer-review started: December 4, 2014 First decision: December 12, 2014 Revised: December 24, 2014 Accepted: January 15, 2015 Article in press: January 19, 2015 Published online: March 26, 2015 Processing time: 99 Days and 23.1 Hours
Core Tip
Core tip: Clinical outcomes in coronary artery disease with type 2 diabetes mellitus (T2DM) are poor despite improvements in medications and other interventions. Although coronary artery bypass grafting is superior to percutaneous coronary intervention in multivessel coronary artery disease with T2DM, selecting the revascularization strategy depends not only on the lesion complexity but also on the patient’s medical history and comorbidities. In these patients, comprehensive risk management with medical and non-pharmacological therapies is indispensable, and confirming whether such risk management is being appropriately achieved is also important. Furthermore, interventions with exercise and diet therapy during the early stages of glucose abnormalities might be effective in preventing the development or progression of T2DM and in reducing the occurrence of cardiovascular events.
